Education and Training
A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery
Phase 1/2 study of ALM-488 to highlight nerves in patients undergoing head & neck surgery.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- drug: ALM-488
Eligibility
Inclusion Criteria:
1. A neoplasm located in the head and neck.
2. Primary surgical treatment is by parotidectomy, or thyroidectomy, or cervical neck
dissection.
3. Can understand and is willing to sign a written informed consent document.
4. ≥18 years of age.
5. Life expectancy of at least 6 months.
6. Normal liver and kidney functions.
7. If of childbearing potential, must have a negative urine or serum pregnancy test and
be using a medically acceptable form of contraception (e.g., hormonal birth control,
intrauterine devices, double-barrier method) or abstinence. The subject, if male, must
use a medically acceptable form of contraception (e.g. condom) or abstinence.
8. Plans to undergo head and neck surgery.
Exclusion Criteria:
1. Prior radiation or chemotherapy for any prior head and neck neoplasm.
2. Open surgery in the ipsilateral head and neck within 1 year.
3. Abnormal cardiac rhythm not controlled with medication, history of stroke, coronary
events and/or heart failure within 1 year.
4. Current evidence of renal disease.
5. Pregnant or breastfeeding.
6. Unresolved acute toxicity from prior anti-cancer therapy.
7. History of fluorescein allergy.
8. Any other criteria deemed by the Principal Investigator that may prevent the patient
from successfully completing the trial.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Grace Yi
650-242-2666
Not Recruiting